Showing results (221-230 of 312) with videos related to

Sort By:
Pageof 32
Journal of Medical Imaging and Radiation Oncology|October 4, 2018
Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid 18 F-fluorodeoxyglucose-positron emission tomography and CT perfusion studyDae-Myoung Yang, David Palma, Alexander Louie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 7, 2025
Opioid therapy vs. Multimodal analgesia in head and neck cancer (OPTIMAL-HN): Results of a randomized clinical trialSondos Zayed, Pencilla Lang, Nancy Read, et al.
European Urology Focus|February 12, 2018
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in NonseminomaRicardo Leão, Madhur Nayan, Nahid Punjani, et al.
European Urology|April 6, 2024
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR StudyRobert J Motzer, Toni K Choueiri, Thomas Hutson, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2015
Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysisGraham D Smith, Tom Pickles, Juanita Crook, et al.
Medical Physics|May 7, 2010
Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imagingIram Munawar, Brian P Yaremko, Jeff Craig, et al.
Practical Radiation Oncology|March 6, 2015
Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guidelineGeorge Rodrigues, Gregory M M Videtic, Ranjan Sur, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129Canhua Xiao, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
Cell Reports. Medicine|May 16, 2026
Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancerPeter Y F Zeng, Jalna Meens, Amir Hossein Karimi, et al.
Oncotarget|October 27, 2017
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancerFarhad Ghasemi, Morgan Black, Frederick Vizeacoumar, et al.
Pageof 32